DEC 21, 2017 6:11 AM PST

Monocyte Diversity Vital for Personalized Cancer Immunotherapy

WRITTEN BY: Kara Marker

Plucking monocytes out of the human bloodstream is one approach to creating personalized cancer treatments, but this immunotherapy approach hasn’t been as successful as scientists hoped it would be. After learning more about monocytes in a new study from the University of Bonn, scientists and their collaborators learn that these cells are much more diverse than they realized.

Dendritic cells in the corneal epithelium. Credit: Wikimedia user Zhiguo.he

Monocytes are circulating white blood cells of the immune system that are made in the bone marrow before they enter the bloodstream and eventually differentiate into the so-called antigen-presenting cells of the immune system: macrophages, phagocytic immune cells, or dendritic cells.

In the past, scientists have extracted monocytes from the blood of cancer patients to use for immunotherapy, creating monocyte-derived dendritic cells (moDCs) to activate the immune system against tumor cells. However, this therapy approach is rarely effective - why? Can it be made more effective?

The new study, published in the journal Immunity, helped scientists realize that moDCs are not identical descendents of dendritic cells; instead, they are actually quite diverse. To analyze moDCs in their new study, scientists isolated monocytes from human blood samples and transformed the cells into different types of antigen-presenting cells.

"Using state-of-the-art computer-assisted models, we were able to show that moDCs differ from dendritic cells and present a mixture of cells with very diverse properties and functions,” explained lead author Jil Sander.

The variety of moDCs likely explains why cancer immunotherapy based on these cells works in so few patients. However, researchers believe that the moDCs could be altered to fit individual cases of cancer, enhancing the immunotherapy’s success rate.

"MoDCs have an extraordinarily large plasticity, enabling them to tailor their response to pathogens, tumors or endogenous danger signals,” explained second lead author Dr. Susanne V. Schmidt. “This ability is fine-tuned by specific gene regulation.”

Sources: PubMed Health, University of Bonn

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 06, 2020
Immunology
APR 06, 2020
Clearing the Path for Dendritic Cells to Eliminate Tumors
  Dendritic cells are the sentinels of the immune system and use their “tree-like” projections to prese ...
APR 17, 2020
Neuroscience
APR 17, 2020
Anti Vaxxers More Paranoid than Average Person
Researchers from Texas Tech University have found that anti-vaxxers (those who deny the efficacy of vaccines) are more p ...
APR 21, 2020
Immunology
APR 21, 2020
Sino Biological Focuses on Serological Studies of COVID-19
April 17, 2020, Sino Biological announced this week that the company launched the world’s first coronavirus antige ...
MAY 04, 2020
Immunology
MAY 04, 2020
GeoVax and Sino Bio Collaborate on COVID-19 Vaccine Work
GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and ...
MAY 02, 2020
Immunology
MAY 02, 2020
Cellular "Cleaning Crews" Get Busy During Spinal Cord Injury
  Nerve cells transmit and receive information traversing the human body in the form of electrical impulses. These ...
MAY 21, 2020
Drug Discovery & Development
MAY 21, 2020
Molecular 'Switch' Makes Autoimmune Drugs Fight Cancer
Researchers from the Antibody and Vaccine Group at the University of Southampton, England, have identified a way to repu ...
Loading Comments...